159 related articles for article (PubMed ID: 3756943)
1. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic evaluation of continuous infusion cisplatin].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hyashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jun; 35(6):955-61. PubMed ID: 2801396
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
Horiuchi M; Inuyama Y; Kohno N; Mashino S; Fujii M
Gan To Kagaku Ryoho; 1982 Apr; 9(4):632-7. PubMed ID: 6892197
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
Belt RJ; Himmelstein KJ; Patton TF; Bannister SJ; Sternson LA; Repta AJ
Cancer Treat Rep; 1979; 63(9-10):1515-21. PubMed ID: 498151
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of carboplatin after i.v. administration.
Elferink F; van der Vijgh WJ; Klein I; Vermorken JB; Gall HE; Pinedo HM
Cancer Treat Rep; 1987 Dec; 71(12):1231-7. PubMed ID: 3319135
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
Forastiere AA; Belliveau JF; Goren MP; Vogel WC; Posner MR; O'Leary GP
Cancer Res; 1988 Jul; 48(13):3869-74. PubMed ID: 3378222
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Hart AA; Gall HE; Pinedo HM
Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
Chen JT; Hasumi K
Gan To Kagaku Ryoho; 1995 Apr; 22(5):653-7. PubMed ID: 7717717
[TBL] [Abstract][Full Text] [Related]
10. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
[TBL] [Abstract][Full Text] [Related]
12. [The pharmacokinetics of cisplatin and its influence on renal functions based on different infusion methods].
Takahashi A; Takagi M; Hishida H; Saji E; Takagi N; Amano H; Ogura Y
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2944-50. PubMed ID: 3116947
[TBL] [Abstract][Full Text] [Related]
13. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
Gamelin E; Bouil AL; Boisdron-Celle M; Turcant A; Delva R; Cailleux A; Krikorian A; Brienza S; Cvitkovic E; Robert J; Larra F; Allain P
Clin Cancer Res; 1997 Jun; 3(6):891-9. PubMed ID: 9815764
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
Kelsen DP; Ribaud P; Alcock N; Burchenal JH; Young CW; Mathe G
Cancer Clin Trials; 1981; 4(4):429-31. PubMed ID: 7318125
[TBL] [Abstract][Full Text] [Related]
16. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.
Dominici C; Petrucci F; Caroli S; Alimonti A; Clerico A; Castello MA
J Clin Oncol; 1989 Jan; 7(1):100-7. PubMed ID: 2909663
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of cisplatin in an anuric patient undergoing hemofiltration dialysis.
Gouyette A; Lemoine R; Adhemar JP; Kleinknecht D; Man NK; Droz JP; Macquet JP
Cancer Treat Rep; 1981; 65(7-8):665-8. PubMed ID: 7195773
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
Patton TF; Himmelstein KJ; Belt R; Bannister SJ; Sternson LA; Repta AJ
Cancer Treat Rep; 1978 Sep; 62(9):1359-62. PubMed ID: 688279
[No Abstract] [Full Text] [Related]
20. Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.
DeGregorio M; Wilbur B; King O; Wallenberg J; Prewitt S; Phillips J; Wilbur J
Cancer Treat Rep; 1986 Dec; 70(12):1437-8. PubMed ID: 3791256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
